NINGBO INNO PHARMCHEM CO.,LTD. is at the forefront of supplying critical research peptides, including the notable Human ezrin peptide (324-337), commonly referred to as HEP-1 (CAS: 174641-44-2). This sophisticated peptide offers a wealth of opportunities for scientific inquiry across multiple disciplines within the biomedical field.

One of the primary research applications of HEP-1 is in the realm of antibody development. Researchers utilize this peptide as an immunogen to generate specific antibodies against the ezrin protein. These antibodies are indispensable tools for various laboratory techniques such as Western blotting, immunohistochemistry, and ELISA, enabling scientists to study the expression patterns, cellular localization, and functional significance of ezrin in both healthy and diseased states. The ability to buy HEP-1 for antibody production is therefore crucial for advancing our understanding of ezrin's cellular roles.

Beyond its use in antibody generation, HEP-1 is instrumental in functional studies. By employing this peptide, researchers can investigate the intricate protein-protein interactions that ezrin engages in. For instance, studies can explore whether HEP-1, by mimicking or blocking specific ezrin binding sites, influences interactions with other key cellular proteins like CD44 or E-cadherin. Such experiments are vital for deciphering the molecular mechanisms underlying cell adhesion, migration, and signal transduction, processes often dysregulated in diseases like cancer.

The peptide's link to ezrin also makes it relevant for cancer research. Abnormal ezrin expression is frequently observed in various cancers, correlating with increased tumor cell migration, invasion, and metastasis. Investigating the role of the ezrin peptide immune response connection, or directly studying the function of the HEP-1 sequence within tumor microenvironments, can shed light on the pathogenesis of these aggressive cancers, potentially identifying new therapeutic targets. The precise sequence, Human ezrin peptide (324-337), is a focus for these investigations.

Moreover, HEP-1's inherent antiviral properties, particularly its anti-HIV activity, open doors for further exploration in the field of infectious diseases. The HEP-1 anti-HIV activity is a significant area of research, aiming to develop new therapeutic agents. Similarly, its capacity to enhance immune responses, as seen in vaccination studies, suggests broader applications in immunology and virology. The pursuit of peptide for antiviral research is significantly bolstered by compounds like HEP-1.

NINGBO INNO PHARMCHEM CO.,LTD. provides researchers with access to high-purity HEP-1, ensuring reliable and reproducible results in their experiments. The HEP-1 vaccination enhancement capabilities further underscore its importance in understanding and improving immune system functions. By supplying this critical research chemical, NINGBO INNO PHARMCHEM CO.,LTD. actively contributes to the progress of scientific discovery and the development of future medical interventions.

In conclusion, Human ezrin peptide (324-337) is a valuable research tool with applications ranging from fundamental molecular biology to applied immunology and virology. Its multifaceted nature makes it a cornerstone for many advanced research projects.